Figure 8: Performance of Nine-lncRNA Prognostic Signature in Validation Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.

doi 10.7717/peerj.6061/fig-8
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

PeerJ

Related search

Figure 5: Performance of Nine-lncRNA Prognostic Signature in Model Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.

English

Figure S2: The Calibration Curves Predicting Overall Survival at (A) 3-Year and (B) 5-Year

English

Figure 3: The Distributions of Nine-lncRNA Prognostic Signature (A), Overall Survival Status and Overall Survival Time (B) in Model Cohort.

English

Table 1: Patient Characteristics and 3- And 5-Year Overall Survival Rates.

English

Figure 7: The Receiver Operating Characteristic (ROC) Curve of the 3-Year Survival Rate.

English

Figure 4: Calibration Curves of the Nomogram Predicting (A) 3-Year and (B) 5-Year Overall Survivals in Patients With Pelvic Ewing Sarcoma.

English

Figure 3: The Kaplan–Meier Overall Survival Curve.

English

Trismus in Patients With Head and Neck Cancer and 5-Year Overall Survival

Acta Oto-Laryngologica
MedicineOtorhinolaryngology
2018English

Pre-Treatment CT Radiomics to Predict 3-Year Overall Survival Following Chemoradiotherapy of Esophageal Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy